The Scientist

» extinction, microbiology and culture

Most Recent

In Chapter 13, “Why Is Reductionism Successful in Art?” author Eric Kandel explores what about abstract art challenges the human brain.

1 Comment

image: How Art Can Inform Brain Science, and Vice Versa

How Art Can Inform Brain Science, and Vice Versa

By | September 1, 2016

Reductionism may be the key to bridging the gap between the humanities and the sciences.

0 Comments

image: Notable Science Quotes

Notable Science Quotes

By | September 1, 2016

Sensory discoveries, open-access publishing, and candidates on climate changes

1 Comment

image: Promoting Protein Partnerships

Promoting Protein Partnerships

By | September 1, 2016

Scientists generate new protein-protein interactions at an impressive PACE.

0 Comments

image: Protein or Perish

Protein or Perish

By | September 1, 2016

A bacteriophage must evolve certain variants of a protein or die.

0 Comments

image: Popular Tumor Cell Line Contaminated

Popular Tumor Cell Line Contaminated

By | August 31, 2016

A commercially available glioblastoma cell line appears to be from a different source than its stated origins.

0 Comments

image: Extinct River Dolphin Species Discovered

Extinct River Dolphin Species Discovered

By | August 16, 2016

Overlooked for half a century, a skull in the Smithsonian collection points to a dolphin species that lived 25 million years ago, according to a study.

0 Comments

image: Antibiotic Resistance Reaches Brazil

Antibiotic Resistance Reaches Brazil

By | August 8, 2016

Scientists detect a colistin-resistance gene in a clinical sample.

0 Comments

image: Study: Last Woolly Mammoths Died of Thirst

Study: Last Woolly Mammoths Died of Thirst

By | August 3, 2016

On remote island near Alaska, salt water intrusion and a warming climate killed off the last remaining survivors of the species.

0 Comments

image: Fecal Transplant Pill Fails Trial

Fecal Transplant Pill Fails Trial

By | August 1, 2016

Seres Therapeutics’s microbiome-targeting therapy for recurrent Clostridium difficile infection fails a Phase 2 clinical trial.

2 Comments

Popular Now

  1. Consilience, Episode 3: Cancer, Obscured
  2. RNAi’s Future in Drug-Target Screening
    News Analysis RNAi’s Future in Drug-Target Screening

    A recent CRISPR study contradicted years of RNA interference research on a well-studied cancer drug target. But is it the last nail in the coffin for RNAi as a screening tool? 

  3. A History of Screening for Natural Products to Fight Cancer
  4. Human Cord Plasma Protein Boosts Cognitive Function in Older Mice
AAAS